CHALLENER, C. A. (2024). Proprietary Cell-Line Development for High-Titer AAV Manufacturing: Proprietary cell lines offer opportunities for achieving high AAV titers. BioPharm International, 37(3), 10-15.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
CHALLENER, CYNTHIA A. "Proprietary Cell-Line Development for High-Titer AAV Manufacturing: Proprietary Cell Lines Offer Opportunities for Achieving High AAV Titers."
BioPharm International 37, no. 3 (2024): 10-15.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
CHALLENER, CYNTHIA A. "Proprietary Cell-Line Development for High-Titer AAV Manufacturing: Proprietary Cell Lines Offer Opportunities for Achieving High AAV Titers."
BioPharm International, vol. 37, no. 3, 2024, pp. 10-15.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.